Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: NTG: NTG plus Lignocaine gel
Dose 1ml (5mg) NTG solution + 1ml of 2% Lignocaine gel applied once topically on the cubital fossa.
Duration of intervention 30mins
Control Intervention1:
Sponsors
Mahatma Gandhi Medical College and Research Institute
Eligibility
Inclusion criteria
Inclusion criteria: - Age above 18 years of any gender - Individuals where the veins in the cubital fossa are not visible after application of tourniquet - BMI between 20 – 30 Kg/m2
Exclusion criteria
Exclusion criteria: - Refusal to participate - Any allergy to the study drugs - Skin lesions over the cubital fossa - Thrombosed or non-collapsibility of cubital fossa veins identified by USG - History of deep vein thrombosis or any other vascular disorder - History of cardiac disease or migraine headaches - Pregnant or lactating females
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the incidence of patients exhibiting visible vein after topical application of study drugs.Timepoint: Every 5 minutes for 30 minutes | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To compare the increase in venous diameter following application of plain lignocaine gel with or without topical NTG application, measured with USG. 2. To observe the onset and duration of vein dilatation. 3. To observe any changes in the skin at site of application – redness or flushing, temperature discrimination. 4. To observe any change in haemodynamics – BP, HR after topical application of study drugsTimepoint: Every 5 mins for 30 minutes | — |
Countries
India
Contacts
Public ContactSRUTHI K
Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth Deemed to be University
Outcome results
None listed